nescovit 300ml syr.
samson - syr. - 300ml
nilbac-m 10 tab
samson - norfloxacin,metronidazole - tab - 400,600;mg - 10
nilbac-m 30ml sus
samson - norfloxacin,metronidazole - sus - 100,100;mg;5ml - 30ml
proxone 10 tab
samson - chlorzoxazone,diclofenac pot.,paracetamol - tab - 250,50,500;mg - 10
cefoxitin injection, powder, for solution
samson medical technologies llc - cefoxitin sodium (unii: q68050h03t) (cefoxitin - unii:6oev9dx57y) - cefoxitin 100 g - to reduce the development of drug-resistant bacteria and maintain the effectiveness of cefoxitin and other antibacterial drugs, cefoxitin for injection, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. cefoxitin for injection, usp is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below. - lower respiratory tract infections, including pneumonia and lung abscess, caused by streptococcus pneumoniae , other streptococci (excluding enterococci, e.g., enterococcus faecalis [formerly streptococcus faecalis ]), staphylococcus aureus (including penicillinase-producing strains), escherichia
ceftriaxone- ceftriaxone sodium injection, powder, for solution
samson medical technologies, llc - ceftriaxone sodium (unii: 023z5br09k) (ceftriaxone - unii:75j73v1629) - ceftriaxone 100 g - to reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftriaxone for injection and other antibacterial drugs, ceftriaxone for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. ceftriaxone for injection is indicated for the treatment of the following infections when caused by susceptible bacteria: lower respiratory tract infections caused by streptococcus pneumoniae, staphylococcus aureus, haemophilus influenzae, haemophilus parainfluenzae, klebsiella pneumoniae, escherichia coli, enterobacter aerogenes, proteus mirabilis or serratia marcescens . skin and skin structure infections caused by staphylococcus aureus, staphylococcus epi
cefuroxime sodium injection powder for solution
samson medical technologies, l.l.c. - cefuroxime sodium (unii: r8a7m9my61) (cefuroxime - unii:o1r9fj93ed) - cefuroxime sodium 75 g
cefazolin- cefazolin sodium injection, powder, lyophilized, for solution
samson medical technologies, l.l.c. - cefazolin sodium (unii: p380m0454z) (cefazolin - unii:ihs69l0y4t) - cefazolin 100 g - to reduce the development of drug-resistant bacteria and maintain the effectiveness of cefazolin and other antibacterial drugs, cefazolin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. cefazolin for injection is indicated for the treatment of the following infections when caused by susceptible bacteria. respiratory tract infections due to streptococcus pneumoniae , staphylococcus aureus and streptococcus pyogenes . injectable benzathine penicillin is considered the drug of choice in treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefazolin is effective in the eradication of streptococci from the nasopharynx; however, dat
vancomycin hydrochloride injection, powder, lyophilized, for solution
samson medical technologies llc - vancomycin hydrochloride (unii: 71wo621tjd) (vancomycin - unii:6q205eh1vu) - vancomycin 100 g - vancomycin hydrochloride for injection, usp is indicated for the treatment of serious or severe infections caused by susceptible strains of methicillin-resistant (beta-lactam-resistant) staphylococci. it is indicated for penicillin-allergic patients, for patients who cannot receive or who have failed to respond to other drugs, including the penicillins or cephalosporins, and for infections caused by vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. vancomycin is indicated for initial therapy when methicillin-resistant staphylococci are suspected, but after susceptibility data are available, therapy should be adjusted accordingly. vancomycin is effective in the treatment of staphylococcal endocarditis. its effectiveness has been documented in other infections due to staphylococci, including septicemia, bone infections, lower respiratory tract infections, and skin and skin-structure infections. when staphylococcal infections are localized and purulent, antibiotics are used as adj
pegasus male sexual enhancer- zinc gluconate capsule
samson pharmaceutical - zinc gluconate (unii: u6wsn5sq1z) (zinc cation - unii:13s1s8sf37) - zinc gluconate 50 mg